Prevalence of prostate cancer in men with haematuria: a systematic review and meta‐analysis

To investigate the prevalence of prostate cancer in men attending evaluation for haematuria, as this could help healthcare providers to determine whether men with haematuria should have prostate examinations performed.

[1]  M. Roobol,et al.  Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. , 2021, European urology.

[2]  Masanori Yamamoto,et al.  Hematuria in Adults. , 2021, The New England journal of medicine.

[3]  Z. Savin,et al.  Flexible Cystoscopy in the Setting of Macroscopic Hematuria: Do the Findings Justify Its Use? , 2021, Urologia Internationalis.

[4]  A. Elliott,et al.  Nurse‐led one stop hematuria clinic: Outcomes from 2,714 patients , 2021, BJUI compass.

[5]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[6]  K. Raza,et al.  Does non-visible haematuria require urgent assessment? A retrospective cohort study from a university teaching hospital , 2021, World Journal of Urology.

[7]  Y. Lotan,et al.  Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. , 2020, The Journal of urology.

[8]  A. Alabousi,et al.  The Diagnostic Yield of CT Urography in the Workup of Hematuria With Negative Cystoscopy , 2020, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[9]  C. Hawks,et al.  Ten‐year outcomes of the first ‘one‐stop haematuria clinic’ in an Australian public hospital , 2019, ANZ journal of surgery.

[10]  Ahmed Abdelhafez.  THE USEFULNESS OF PROSTATE SPECIFIC ANTIGEN SCREENING IN MALE PATIENTS PRESENTED WITH HAEMATURIA , 2019 .

[11]  E. Messing,et al.  Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. , 2019, European urology.

[12]  Tove Faber Frandsen,et al.  Searching for qualitative health research required several databases and alternative search strategies: a study of coverage in bibliographic databases. , 2019, Journal of clinical epidemiology.

[13]  Y. Lotan,et al.  Evaluation of Hematuria in a Large Public Health Care System , 2019, Bladder cancer.

[14]  P. Davidson,et al.  Inclusion of a molecular marker of bladder cancer in a clinical pathway for investigation of haematuria may reduce the need for cystoscopy. , 2019, The New Zealand medical journal.

[15]  Ewout W Steyerberg,et al.  Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. , 2019, The Cochrane database of systematic reviews.

[16]  P. Boström,et al.  Progress towards a Nordic standard for the investigation of hematuria: 2019 , 2019, Scandinavian journal of urology.

[17]  Bernard N. Kafor,et al.  Haematuria in Benign, Prostatic Hyperplasia and Prostatic Carcinoma , 2019 .

[18]  Bashar Mohammed Hobi,et al.  Pioneer Data for Initiating Prostate Cancer National Screening Program in Baghdad , 2019, Indian Journal of Public Health Research & Development.

[19]  H. Sørensen,et al.  Evaluation of Hospital-Based Hematuria Diagnosis and Subsequent Cancer Risk Among Adults in Denmark , 2018, JAMA network open.

[20]  N. Qi,et al.  Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma , 2018, Cancer management and research.

[21]  A. Feber,et al.  Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients. , 2018, European urology.

[22]  N. Iqbal,et al.  Clinicopathological Characteristics of Prostate Cancer in Patients Presenting to a Tertiary Care Private Sector Hospital. , 2018, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[23]  M. Page,et al.  Registration of systematic reviews in PROSPERO: 30,000 records and counting , 2018, Systematic Reviews.

[24]  C. Obiorah,et al.  The Role of Dutasteride in Acute Prostatic Haematuria , 2017 .

[25]  A. Eisenhardt,et al.  Haematuria work‐up in general care—A German observational study , 2017, International journal of clinical practice.

[26]  S. Chan,et al.  Differences in cancer characteristics of Chinese patients with prostate cancer who present with different symptoms. , 2016, Hong Kong medical journal = Xianggang yi xue za zhi.

[27]  A. Charlett,et al.  Study quality assessment tools , 2016 .

[28]  W. Hamilton,et al.  The association between symptoms and bladder or renal tract cancer in primary care: a systematic review. , 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

[29]  J. Patard,et al.  Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome. , 2015, Urologic oncology.

[30]  Jsa Green,et al.  Quantifying the risk of malignancy in patients with visible haematuria presenting to the emergency department , 2015 .

[31]  S. Horie,et al.  Isomorphic red blood cells using automated urine flow cytometry is a reliable method in diagnosis of bladder cancer , 2014, International Journal of Clinical Oncology.

[32]  Yiran Huang,et al.  Ductal adenocarcinoma of the prostate: immunohistochemical findings and clinical significance , 2013, OncoTargets and therapy.

[33]  Jan J Barendregt,et al.  Meta-analysis of prevalence , 2013, Journal of Epidemiology & Community Health.

[34]  S. Jacobsen,et al.  Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. , 2013, Mayo Clinic proceedings.

[35]  Scott D. Miller,et al.  Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. , 2012, The Journal of urology.

[36]  B. Somani,et al.  Half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup. , 2012, The Journal of urology.

[37]  S. Goonewardena,et al.  Pattern of urological malignancies in 2010 – an audit from a tertiary referral centre , 2012 .

[38]  L. Carmignani,et al.  Hematuria One Stop Clinic: First Experience in Italy with 150 Cases , 2011, Urologia.

[39]  N. Vasdev,et al.  Has the introduction of the ‘2 week rule’ in the UK led to an earlier diagnosis of urological malignancy? , 2011, Ecancermedicalscience.

[40]  K. Chan,et al.  Three-Year Outcomes of a Visible Haematuria Clinic—No Initial Role for Urine Cytology? , 2010 .

[41]  T. Badmus,et al.  Burden of prostate cancer in southwestern Nigeria. , 2010, Urology.

[42]  S. Chandrasekharan,et al.  PSA Testing of Men in the Haematuria Clinic, a Useful Additional Test or Unnecessary Investigation , 2010 .

[43]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[44]  T. Ebert,et al.  Immunocytology in the assessment of patients with asymptomatic hematuria , 2008, World Journal of Urology.

[45]  H. Samaratunga,et al.  Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp , 2007, Pathology.

[46]  K. Ghani,et al.  COMPUTED TOMOGRAPHY UROGRAPHY FOR DIAGNOSING BLADDER CANCER , 2007, BJU international.

[47]  D. Giannakis,et al.  Multi-Detector row CT urography on a 16-row CT scanner in the evaluation of urothelial tumors , 2007, European Radiology.

[48]  S. Payne,et al.  The use of prostate‐specific antigen testing in men presenting with haematuria , 2006, BJU international.

[49]  T. Peters,et al.  Clinical features of prostate cancer before diagnosis: a population-based, case-control study. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.

[50]  H. Hedelin,et al.  Screening for bladder tumours in men aged 60–70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy , 2006, Scandinavian journal of urology and nephrology.

[51]  P. Kincaid‐smith,et al.  The investigation of hematuria. , 2005, Seminars in nephrology.

[52]  Da-Lung Chen,et al.  Hematuria: Analysis of 738 Outpatients , 2005 .

[53]  N. Minkov,et al.  Profuse haematuria , 2005, International Urology and Nephrology.

[54]  C. Oranusi,et al.  Cancer Of The Prostate: Experience At Nnewi, Southeast, Nigeria , 2004 .

[55]  N. Dublin.  Prostate biopsies--a retrospective review from the University Malaya Medical Center. , 2003, The Medical journal of Malaysia.

[56]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[57]  Ingram Olkin,et al.  Adjusting for publication bias in the presence of heterogeneity , 2003, Statistics in medicine.

[58]  X. Gamé,et al.  Comparison of red blood cell volume distribution curves and phase-contrast microscopy in localization of the origin of hematuria. , 2003, Urology.

[59]  F. Buntinx,et al.  The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. , 2003, The British journal of general practice : the journal of the Royal College of General Practitioners.

[60]  P. D. Ekwere,et al.  The changing pattern of prostate cancer in Nigerians: current status in the southeastern states. , 2002, Journal of the National Medical Association.

[61]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[62]  A. Rigby,et al.  Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.

[63]  I. Palacios,et al.  Frequency of gross hematuria shortly after percutaneous coronary intervention. , 2001, The American journal of cardiology.

[64]  R. Chahal,et al.  Is It Necessary to Perform Urine Cytology in Screening Patients with Haematuria? , 2001, European Urology.

[65]  K. Sugimura,et al.  Microscopic hematuria as a screening marker for urinary tract malignancies , 2001, International journal of urology : official journal of the Japanese Urological Association.

[66]  S. Holmäng,et al.  The results of routine evaluation of adult patients with haematuria analysed according to referral form information with 2-year follow-up. , 2001, Scandinavian journal of urology and nephrology.

[67]  S. Foley,et al.  Haematuria; a late complication of TURP? , 2001, Prostate Cancer and Prostatic Diseases.

[68]  D. Neal,et al.  A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. , 2000, The Journal of urology.

[69]  K Koiso,et al.  Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria , 1999, International journal of urology : official journal of the Japanese Urological Association.

[70]  P. Walsh,et al.  The epidemiology of prostate cancer in Jamaica. , 1998, Journal of Urology.

[71]  F. Buntinx,et al.  The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis. , 1997, Family practice.

[72]  D. Osegbe.  Prostate cancer in Nigerians: facts and nonfacts. , 1997, The Journal of urology.

[73]  E. Millar,et al.  Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathological study of 16 cases , 1996, Histopathology.

[74]  E. Messing,et al.  Hematuria home screening: repeat testing results. , 1995, The Journal of urology.

[75]  C. Lawton,et al.  Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms? , 1994, Radiology.

[76]  R. Hiatt,et al.  Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[77]  K. Miyake,et al.  Etiology of asymptomatic microscopic hematuria in adults. , 1993, Hinyokika kiyo. Acta urologica Japonica.

[78]  E. Messing,et al.  Home screening for hematuria: results of a multiclinic study. , 1992, The Journal of urology.

[79]  T. Igarashi,et al.  Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients. , 1990, The Journal of urology.

[80]  B. C. Choi,et al.  Microscopic haematuria as a predictor of urological diseases among steel workers. , 1990, The Journal of the Society of Occupational Medicine.

[81]  M. Benson,et al.  Prostate cancer in men less than 45 years old: influence of stage, grade and therapy. , 1987, The Journal of urology.

[82]  L. Melton,et al.  Isolated asymptomatic microhematuria: a cross-sectional analysis of test-positive and test-negative patients. , 1987, Journal of general internal medicine.

[83]  G. Kopelson,et al.  Periurethral prostatic duct carcinoma. Clinical features and treatment results , 1978, Cancer.

[84]  J. Seebode,et al.  Biologic and pathophysiologic prognosticating indices in prostatic cancer. , 1978, The American surgeon.

[85]  R. Carpenter,et al.  Natural history of prostatic obstruction. A prospective survey. , 1969, The Journal of the Royal College of General Practitioners.